| Stereochemistry | ABSOLUTE |
| Molecular Formula | C10H13FN2O4 |
| Molecular Weight | 243.2222 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CN([C@H]2C[C@H]([18F])[C@@H](CO)O2)C(=O)NC1=O
InChI
InChIKey=UXCAQJAQSWSNPQ-ZIVQXEJRSA-N
InChI=1S/C10H13FN2O4/c1-5-3-13(10(16)12-9(5)15)8-2-6(11)7(4-14)17-8/h3,6-8,14H,2,4H2,1H3,(H,12,15,16)/t6-,7+,8+/m0/s1/i11-1
| Molecular Formula | C10H13FN2O4 |
| Molecular Weight | 243.2222 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
3'-[(18)F]fluoro-3'-deoxythymidine [[(18)F]-FLT or ALOVUDINE F-18], a tracer for positron emission tomography (PET) that is used for imaging of proliferation in human malignant lymphoma. This compound is also useful for making a proper diagnosis and monitoring treatment response of aplastic anemia patients, because can show overview of the bone marrow compartment in aplastic anemia.
